IP Verse

Greiner patent opposition analysis

The comprehensive analysis of Greiner opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Greiner

Stay updated with the latest patent oppositions filed by Greiner

Patent Number	Title	Applicant	Opposition Date	Opposition Company
EP3411021	New Use Of A Combination Of Sacubitril And Valsartan	NOVARTIS	Feb 13, 2026	ZENTIVA KS
EP4212152	Sacubitril-Valsartan Dosage Regimen For Treating Heart Failure	NOVARTIS	Jan 30, 2026	ZENTIVA
EP4125903	Methods For Dose Initiation Of Aripiprazole Treatments	OTSUKA PHARMACEUTICAL	Jul 9, 2025	ZENTIVA
EP4321157	New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)	NOVARTIS	Jun 25, 2025	ZENTIVA KS
EP3815688	Pharmaceutical Composition Containing Poorly-Soluble Basic Medicine	CHUGAI SEIYAKU KABUSHIKI KAISHA	Sep 6, 2024	SANDOZ
EP3626270	New Use	NOVARTIS	Jul 11, 2024	ZENTIVA KS
EP3294283	Sacubitril-Valsartan Dosage Regimen For Treating Heart Failure	NOVARTIS	Dec 8, 2023	ZENTIVA
EP3345607	Methods Of Altering Bone Growth By Administration Of Sost Or Wise Antagonist Or Agonist	OSTEOQC	Jul 26, 2023	AMGEN EUROPE
EP3827845	Subcutaneous Formulations Of Anti-Cd38 Antibodies And Their Uses	JANSSEN BIOTECH	Dec 27, 2022	KONIG SZYNKA TILMANN VON RENESSE
EP2959894	S1P Receptor Modulators For Treating Multiple Sclerosis	NOVARTIS	Nov 21, 2022	A MED

Top clients of Greiner

Top companies who are the clients of Greiner

Company	Total
ZENTIVA	8
GREINER	6
ZENTIVA KS	5
TEVA PHARMACEUTICALS	3
DF MP DRRIES FRANK MOLNIA & POHLMAN	3
DF MP DORRIES FRANK MOLNIA & POHLMAN PATENTANWALTE RECHTSANWALTE PARG MBB	3
PHARMA STULLN	2
SANDOZ	2
ZENTIVA GROUP	1
HEXAL	1